X-16946900-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_004726.3(REPS2):āc.39A>Gā(p.Ala13Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00123 in 774,534 control chromosomes in the GnomAD database, including 6 homozygotes. There are 204 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Genomes: š 0.0059 ( 3 hom., 107 hem., cov: 20)
Exomes š: 0.00054 ( 3 hom. 97 hem. )
Consequence
REPS2
NM_004726.3 synonymous
NM_004726.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.98
Genes affected
REPS2 (HGNC:9963): (RALBP1 associated Eps domain containing 2) The product of this gene is part of a protein complex that regulates the endocytosis of growth factor receptors. The encoded protein directly interacts with a GTPase activating protein that functions downstream of the small G protein Ral. Its expression can negatively affect receptor internalization and inhibit growth factor signaling. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BP6
Variant X-16946900-A-G is Benign according to our data. Variant chrX-16946900-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 783904.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.98 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00593 (590/99547) while in subpopulation AFR AF= 0.0199 (551/27687). AF 95% confidence interval is 0.0185. There are 3 homozygotes in gnomad4. There are 107 alleles in male gnomad4 subpopulation. Median coverage is 20. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 3 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
REPS2 | NM_004726.3 | c.39A>G | p.Ala13Ala | synonymous_variant | 1/18 | ENST00000357277.8 | NP_004717.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
REPS2 | ENST00000357277.8 | c.39A>G | p.Ala13Ala | synonymous_variant | 1/18 | 1 | NM_004726.3 | ENSP00000349824.3 | ||
REPS2 | ENST00000303843.7 | c.39A>G | p.Ala13Ala | synonymous_variant | 1/18 | 1 | ENSP00000306033.7 |
Frequencies
GnomAD3 genomes AF: 0.00595 AC: 592AN: 99502Hom.: 3 Cov.: 20 AF XY: 0.00399 AC XY: 108AN XY: 27086
GnomAD3 genomes
AF:
AC:
592
AN:
99502
Hom.:
Cov.:
20
AF XY:
AC XY:
108
AN XY:
27086
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.000539 AC: 364AN: 674987Hom.: 3 Cov.: 27 AF XY: 0.000473 AC XY: 97AN XY: 204971
GnomAD4 exome
AF:
AC:
364
AN:
674987
Hom.:
Cov.:
27
AF XY:
AC XY:
97
AN XY:
204971
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00593 AC: 590AN: 99547Hom.: 3 Cov.: 20 AF XY: 0.00394 AC XY: 107AN XY: 27133
GnomAD4 genome
AF:
AC:
590
AN:
99547
Hom.:
Cov.:
20
AF XY:
AC XY:
107
AN XY:
27133
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at